After the closing bell on Monday, Express Scripts ESRX will be releasing its first quarter earnings results. Wall Street analysts are estimating that the company will earn $0.69 per share compared to $0.55 in the year ago period. Over the last 90 days, EPS estimates have risen $0.04, indicating that analysts are becoming more bullish on ESRX's prospects. Revenues are anticipated to be $11.56 billion.
ESRX has been trading in a range over the last 3 months between $58 and $52. During that time period, the stock has lost around 3%. Over the last year, ESRX has climbed 7%. The all-time high of $58.77 in the stock could be breached on a very strong earnings report today. On a longer term basis, ESRX has been showing excellent growth which is reflected in its share price which has risen 164% on the 5-year chart and 890% over the last 10 years.
Express Scripts, Inc. is a pharmacy benefit management (PBM) operating in North America, offering a range of services to its clients, which include health maintenance organizations (HMOs), health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans and Government health programs.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: EarningsNewsIntraday UpdateMoversHealth CareHealth Care ServicesMaterialsPrecious Metals & Minerals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in